Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)
Authors
Keywords
autosomal dominant polycystic kidney disease, clinical trial, estimated glomerular filtration rate, metformin, total kidney volume
Journal
KIDNEY INTERNATIONAL
Volume 100, Issue 3, Pages 684-696
Publisher
Elsevier BV
Online
2021-06-27
DOI
10.1016/j.kint.2021.06.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The genetic landscape of polycystic kidney disease in Ireland
- (2021) Katherine A. Benson et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Autosomal dominant polycystic kidney disease
- (2019) Emilie Cornec-Le Gall et al. LANCET
- Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease
- (2019) Wouter N. Leonhard et al. EBioMedicine
- Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease
- (2019) Katharina Hopp et al. KIDNEY INTERNATIONAL
- Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease
- (2018) Emilie Cornec-Le Gall et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A Randomized Clinical Trial of Metformin to Treat Autosomal Dominant Polycystic Kidney Disease
- (2018) Stephen L. Seliger et al. AMERICAN JOURNAL OF NEPHROLOGY
- A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan
- (2018) Fouad T. Chebib et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Metabolism and mitochondria in polycystic kidney disease research and therapy
- (2018) Valeria Padovano et al. Nature Reviews Nephrology
- Addressing the Need for Clinical Trial End Points in Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC)
- (2018) Kimberly A. Smith et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The combination of metformin and 2-deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease
- (2018) Xiaoying Lian et al. BRITISH JOURNAL OF PHARMACOLOGY
- Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
- (2017) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease
- (2016) C. M. Heyer et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease
- (2016) Luis F. Menezes et al. EBioMedicine
- The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease
- (2015) E. Cornec-Le Gall et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Imaging Classification of Autosomal Dominant Polycystic Kidney Disease: A Simple Model for Selecting Patients for Clinical Trials
- (2014) M. V. Irazabal et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The management of patients with polycystic ovary syndrome
- (2014) Channa N. Jayasena et al. Nature Reviews Endocrinology
- Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease
- (2014) Robert W. Schrier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease
- (2014) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
- (2013) Russell A. Miller et al. NATURE
- Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy
- (2013) Isaline Rowe et al. NATURE MEDICINE
- AMP-activated protein kinase regulation of kidney tubular transport
- (2012) Núria M. Pastor-Soler et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2012) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recommendations for Planning Pilot Studies in Clinical and Translational Research
- (2011) Charity G. Moore et al. CTS-Clinical and Translational Science
- Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis
- (2011) V. Takiar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline
- (2008) Philip E. Cryer et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Unified Criteria for Ultrasonographic Diagnosis of ADPKD
- (2008) Y. Pei et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started